Position in LLY
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$7,685,948
+$1,156,501 QoQ
Shares Held
6,408
-9.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,410
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Procyon Advisors, LLC holds $38,982,476 across 11 Drug Manufacturers - General names. LLY ranks #3 (19.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
32,392 | $8,151,122 | |
| 2 | JNJ |
Johnson & Johnson
|
30,495 | $7,744,815 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
6,408 | $7,685,948 | |
| 4 | MRK |
Merck & Co., Inc.
|
50,916 | $6,542,706 | |
| 5 | AMGN |
Amgen Inc
|
6,850 | $2,480,522 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
17,103 | $2,160,793 | |
| 7 | PFE |
Pfizer Inc
|
55,347 | $1,332,755 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,718 | $963,291 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,685,948 | 6,408 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $6,529,447 | 7,099 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $7,766,713 | 7,227 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $1,992,193 | 2,611 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $2,008,069 | 2,576 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $3,497,728 | 4,235 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $3,043,224 | 3,942 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $3,121,166 | 3,523 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $3,263,894 | 3,605 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $2,795,210 | 3,593 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $2,229,086 | 3,824 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $1,777,900 | 3,310 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $1,135,869 | 2,422 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $797,421 | 2,322 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $766,068 | 2,094 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $431,348 | 1,334 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $532,385 | 1,642 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $464,492 | 1,622 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $533,104 | 1,930 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $468,107 | 2,026 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $460,417 | 2,006 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $360,749 | 1,931 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $326,198 | 1,932 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $326,680 | 2,207 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $352,166 | 2,145 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $327,795 | 2,363 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||